As of 2024-12-15, the Relative Valuation of Edgewise Therapeutics Inc (EWTX) is (35.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.62 USD, the upside of Edgewise Therapeutics Inc based on Relative Valuation is -227.5%.
The range of the Relative Valuation is (32.68) - (38.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 29.2x | 26.6x |
| Forward P/E multiples | 24.9x - 29.2x | 27.0x |
| Fair Price | (32.68) - (38.33) | (35.21) |
| Upside | -218.3% - -238.8% | -227.5% |
| Date | P/E |
| 2024-12-04 | -24.42 |
| 2024-12-03 | -24.35 |
| 2024-12-02 | -24.03 |
| 2024-11-29 | -25.14 |
| 2024-11-27 | -24.53 |
| 2024-11-26 | -24.44 |
| 2024-11-25 | -24.36 |
| 2024-11-22 | -24.53 |
| 2024-11-21 | -24.36 |
| 2024-11-20 | -24.34 |
| 2024-11-19 | -24.01 |
| 2024-11-18 | -23.46 |
| 2024-11-15 | -23.95 |
| 2024-11-14 | -25.04 |
| 2024-11-13 | -25.34 |
| 2024-11-12 | -26.82 |
| 2024-11-11 | -26.92 |
| 2024-11-08 | -27.72 |
| 2024-11-07 | -26.99 |
| 2024-11-06 | -27.90 |
| 2024-11-05 | -27.38 |
| 2024-11-04 | -26.27 |
| 2024-11-01 | -25.90 |
| 2024-10-31 | -25.57 |
| 2024-10-30 | -25.38 |
| 2024-10-29 | -26.24 |
| 2024-10-28 | -25.93 |
| 2024-10-25 | -26.65 |
| 2024-10-24 | -26.37 |
| 2024-10-23 | -26.52 |
| 2024-10-22 | -26.22 |
| 2024-10-21 | -26.55 |
| 2024-10-18 | -27.10 |
| 2024-10-17 | -27.05 |
| 2024-10-16 | -26.69 |
| 2024-10-15 | -25.13 |
| 2024-10-14 | -24.24 |
| 2024-10-11 | -24.32 |
| 2024-10-10 | -22.85 |
| 2024-10-09 | -23.11 |
| 2024-10-08 | -21.70 |
| 2024-10-07 | -21.03 |
| 2024-10-04 | -21.64 |
| 2024-10-03 | -20.29 |
| 2024-10-02 | -20.77 |
| 2024-10-01 | -20.81 |
| 2024-09-30 | -20.33 |
| 2024-09-27 | -19.88 |
| 2024-09-26 | -19.80 |
| 2024-09-25 | -19.71 |